ORGAN EXTRACT- AND CELL THERAPY
FOR CHRONIC DEGENERATIVE DISEASES
The human body contains some four trillion cells, which all arose after conception from one
unified cell through multiple cycles of division. This process of cellular renewal continues
throughout life, as old and weak cells are replaced by new ones. In healthy young individuals the
division of cells takes place regularly in an energetic and balanced bio-terrain. However, as we
grow older, this process begins to slow down. Improper nutrition with large amounts of animal
fat, processed sugars, food additives and too little of biologically grown vegetables, life styles
with heavy smoking, excessive alcohol consumption, an overall increase in stress due to our fast-
paced lives, pollution with carcinogenic solvents, heavy metals and pesticides tend to suppress
this renewal process even more. As a result we age prematurely and even fall ill with chronic
degenerative diseases or cancer.
Organ extract- and cell therapy offers a unique opportunity of causative treatment in this context,
since it can prevent premature cell death or malfunction, induce cellular renewal and restore lost
function of specific cell types in the human body.
Most of us hope for a long meaningful life and nobody wants to be burdened with poor health,
fast degeneration, or pain as they age. Throughout history, mankind always has searched for the
proverbial "fountain of youth". Our modern conventional health care systems have indeed
brought us a longer life expectancy through high-tech medicine and acute crisis management.
However, they have failed terribly in the fields of premature ageing, chronic degenerative
diseases and cancer. It is hoped that the knowledge gained from empirical, bio-energetic and
integrated biological medicine will impart a longer life with vitality. We are all aware of show
business personalities and other celebrities of our time, for whom the ageing process appears to
have stopped. They continue to look well, be attractive, and they are in great shape, even in old
age. Certainly, healthy nutrition, exercise and plastic surgery may play an important role here,
but with more than mere appearance, these famous people continue to exude an aura and body
language that identifies them with younger age groups. The reason is that many of them frequent
the famous clinic spas and medical centres in Europe, including the Niehans, Paracelsus and
Aeskulap Clinics, which specialise in regeneration and, specifically, in the medically respected
technique of organ extract and cell therapy. This treatment modality has made it possible for
these celebrities to maintain a very active lifestyle that otherwise would be impossible. The
recipients seem to retain the vitality of youth, making it possible to enjoy the fruits of success
well into their senior years.
WHAT IS ORGAN EXTRACT- AND CELL THERAPY?
In organ extract- and cellular therapy, cells or extracts of foetal tissue are administered via
intramuscular injection into the human body for therapeutic purposes. These cells are then
broken down into their basic elements (enzymes, polypeptides, deoxyribonucleic acids,
ribonucleic acids and other basic organic substances) and reused by the cells, tissues and organs
of the person treated. The fundamental theory behind organ extract and cell therapy is the
principle `Similia Similibus' or `Like Cures Like', as stated by Paracelsus, a Swiss physician and
philosopher of the 16th century. Paracelsus and many other early physicians believed that the best
way to rebuild or revitalise ill organs or ageing tissue was to use healthy living cells of the same
tissue type. Modern organ extract- and cell therapy refers to treatment by injection with cellular
elements and whole cells from healthy unborn or foetal sheep or calves specially bred for
medical purposes under a controlled environment. Organ extract- and cell therapy actually
"wakes up" dormant cells within the human body, thereby stimulating the growth and function of
existing tissue and repairing or regenerating old and malfunctioning cells. Organ extract- and cell
therapy offers something that vitamins, minerals and other conventional or natural treatments
cannot. It can provide the exact components necessary for injured or diseased tissue to heal and
regenerate. While most pharmaceutical drugs work by suppressing certain symptoms over a short
period of time and only as long as they are taken, organ extract- and cell therapy stimulate the
body's own healing and revitalising powers and exert a long term effect.
THE HISTORY AND DEVELOPMENT OF ORGAN EXTRACT- AND CELL
Organ extract- and cell therapy dates back thousands of years. Written in 1600 B.C., the Eber
Papyrus of medicine recommended injection of animal organs to improve human vitality. In the
Middle Ages, Parcelcus observed, for the first time, the organisational unit of all life, the cell,
was the element in `like heals like'.
In the late 19th century, French Nobel laureate Dr. Alexis Carrel discovered the potentially
immortal nature of cells. He was able to keep alive fragments of a chicken heart for 25 years
after the fowl had died by combining cellular material from different hearts into his cell culture.
At about the same time Paris physiologist C.E. Brown-Sequard recognised the potency of
cellular therapy by injecting himself with an extract made from the testicles of a young bull to
increase his virility. In the 1920's, ophthalmologist Vladimir Filatov initiated the application of
foetal cellular and aloe plant extract therapies for non-specific rejuvenation of chronically ill
patients. His earliest claimed successes were in reversing retinitis pigmentosa and involutional
retinal macular degeneration.
Modern organ extract- and cell therapy began in the 1930's, when the Swiss surgeon Paul
Niehans first discovered that cells derived from the organs of foetal sheep could be injected into
the human body without triggering the natural immune defence mechanism that acts to reject
foreign protein. In 1931, Niehans was summoned to an emergency operation where he was
requested to perform a transplant for an elderly woman whose parathyroid glands were
accidentally removed during a thyroid surgery. The patient was in critical condition and in a race
against time, Niehans sought instead to inject the woman with a steer`s parathyroid cells
suspended in a saline solution, crudely prepared at the scene. The woman`s condition quickly
stabilised and continued to improve as she went on to live another 30 years. In the forty years
following his first successful experiments, Niehans applied his discoveries in cellular therapy
over 50,000 times. Among Niehans' patients were celebrities Charles Chaplin, Robert
Cummings, Joan Crawford, Charles de Gaulle, Dwight and Marnie Eisenhower, Winston
Churchill, Charles Boyer, Bernard Baruch, the Duke and Duchess of Windsor, Joseph Kennedy,
and many others. In 1953, Niehans was called to the bedside of a dying Pope Pius XII. In
gratitude for successful cell therapy, Niehans was invited to become a member of the Papal
Academy of Sciences. Due to its success, European physicians slowly began to accept Niehans'
work with cell therapy. Organ extract- and cellular therapy was on the way to becoming an
accepted regenerative technique in Europe.
Niehans continued his research and work into the 1960's, publishing extensively, only
interrupted by World War II. His major opus on theory and practice of cellular therapy was
published in German in 1954. Niehans later collaborated with Bauer of Clarens Clinic in
Switzerland in studying the therapeutic effects of fresh and preserved cells. He developed the
freeze-drying process of fresh cells termed lyophilization. He used cells from the frontal brain to
treat mongolism. He used skin and eye cellular extracts to treat albinism, injected liver cells to
treat cirrhosis, and utilised testicle cells to treat impotence. Swiss publisher Thorne released the
English version and update of Niehans' original work which also included papers by researchers
from Germany, Austria, Greece and Spain.
Over the years, organ extract- and cell therapy was perfected and found most beneficial for
revitalisation of the body's immune system and its defence mechanisms. When damage occurs to
cells that make up the various tissues and organs that are part of the immune system, the body
becomes defenceless against both external invasion and internal degeneration. Damage to organs
of the immune system can be reversed with cellular therapy. New and energetic cells act quickly
and effectively to stimulate the body's defence mechanisms, allowing for revitalisation and
regeneration, thereby restoring health, vitality and physical power.
THE SCIENCE IN ORGAN EXTRACT- AND CELL THERAPY
To date over one thousand scientific studies have demonstrated the effectiveness of cell therapy.
By radioactively marking organ extract- and cell therapy material, researchers have been able to
ascertain what exactly happens with it after injection. It was found that within forty eight hours
of administration, 90% of cell extract of the liver for example is attracted to its respective organ,
making its way to its destination. The cells then produce the power for the organ to mend itself.
In the 1970's, Letre and Schmid from the University of Heidelberg, Germany, demonstrated that
radioactively marked foetal cells invariably ended up in the target organ. This research verified
animal cellular material was transported by the human host's blood to its counterpart organs and
tissues. Later Kment from the University of Vienna experimented with old rats and their ability
to learn, perceive, and heal after tissue laceration. Kment concluded that older animals injected
with cell therapy showed improved mental acuity and a faster healing. His extensive work in
Austria in the 1970's indicated that cellular therapy improved cognitive abilities, connective
tissue elasticity and tissue respiration. By the late 1970's, a large number of experiments had
been conducted on cell therapy yielding empirical results. Improvement was seen with its use for
a wide range of diagnoses, including chronic degenerative diseases and genetic malfunction in
While organ extract- and cell therapy specialists were working in Europe along the lines
suggested by the late Paul Niehans of Switzerland, the U.S. allopathic community in the 1980's
had begun to move into the arena through various alternate routes. Many of these physicians and
scientists were seemingly oblivious to the fact that they were simply corroborating the theories
and postulates of the `unorthodox' European cellular therapy and solid-state biophysics pioneers
of decades earlier.
The 1980's was a decade in which allopathic medicine began to legitimise cell therapy (to find
some way to fit it into the allopathic paradigm and alter semantics while doing so) began with
Dr. Michael Osband whose work was published in the New England Journal of Medicine in
1981. He showed that 10 of 17 children treated for the immunosuppressive condition called
Histiocytosis X underwent complete remission after being treated with daily intramuscular
injections of thymus extract from five day old calves. This was the first reported use of a non-
human organ extract- and cell therapy in the U.S.
In 1983, the American Paralysis Association convention was told that cells taken from human
aborted foeti and injected into animals had provided evidence of being useful in repair of spinal
cord accidents and degenerative diseases.
In January 1988, The Los Angeles Times reported on the work of Dr. Kevin Lafferty from the
University of Colorado Medical Centre, who saw `good results' in 6 of 17 diabetic patients
treated with implanted cells from foetal pancreases. The Times also reported that about 200
patients worldwide had received foetal liver cells, primarily to restore bone marrow loss as a
result of cancer therapy.
Robert P. Gale, M.D., of University of California, Los Angeles had implanted foetal liver cells
into six radiation victims of the previous Soviet Union's 1986 Chernobyl nuclear disaster. Here
was an ironic case in which American researchers were utilising a form of therapy the American
medical establishment still considered to be unproven at best, quackery at worst, to help save
lives in a foreign country.
Allopathic medicine regards Parkinson's disease as an incurable condition. In the late 1980's, a
wheelchair bound victim of Parkinson's was the first American to undergo what the American
medical establishment decided to call `human foetal cell transplantation therapy' .This new
designation, was hoped to be distanced from the line of medical research of cellular therapy; the
European animal embryo based treatments the allopathic industrial cartel in the United States
had long written off as medium tech quackery. Ongoing orthodox research into the Parkinson's
case had shown that since the 1989 injection of brain tissue from an aborted human foetus, the
patient's Parkinson's symptoms had lessened by 50%. Unfortunately for the pharmaceutical
industry, nothing about cell therapy is patentable, or highly profitable, nor does it consign a
patient to endless expensive courses of therapy.
Dr. Mitchell Golbus of the University of California in San Francisco had unsuccessfully
attempted to transplant adult tissue into human foeti to cure genetic conditions. The fact that an
American university would try to inject adult cells indicated just how provincial the U.S.
healthcare system could be. For classical European organ extract- and cell therapy practitioners
who utilise animal embryonic, foetal or placental tissue injected subcutaneously, the interest of
the Americans into human cell therapy borders on the laughable. Why would they utilise adult
human tissue? And why would they directly graft into the brain or any other organ, which is
risky and potentially dangerous?
In October 1991 and as a follow up in February 1992, American researchers were also reporting
early success with foetus to foetus cell therapy with a severe genetic abnormality known as
Hurler's Syndrome. Ismail Zanjani of the University of Nevada in Reno reported that
transplanted human foetal tissue had `taken hold' in an infant born a year before, with the child's
blood making cells of the transplanted tissue. The developing foetus had been injected with
foetal cells from an aborted human foetus in a controversial application of therapy. The parents
of this child had also lost two children prior to this to mucopolysaccharidosis syndrome, which
causes crippling skeletal problems, blindness and severe mental retardation. The case brought to
the public eye the controversy of using human foetal tissue in experimental therapy.
HOW CONTROVERSIAL IS ORGAN EXTRACT- AND CELL THERAPY?
Be aware that many doctors, unknowingly and without study, have referred to organ extract- and
cell therapy as an "unscientific" treatment. Those physicians are not aware of, or refuse to read,
any of the over 1000 scientific publications that have already been written in this field. Nor are
they aware of the over 8,000,000 patients that have already safely received organ extract- and
cell therapy in Europe, in centres which are under Swiss, Russian and German government
sanction. On the other hand, such uninformed critique disappears when we refer to the treatments
used today by allopathic physicians, such as hormones and enzymes, which are extracted from
animals, or to collagen, which is injected by plastic surgeons to smooth out wrinkles. Non-
human (lamb) foetal cellular and extract therapies were first developed in Germany, Russia and
Switzerland in the 1920's. The rationale of this organ extract- and cell therapy is to approach
chronic viral, degenerative, congenital, allergic, and some cancerous diseases from an entirely
different direction than that of allopathic pharmaceutical (drug oriented) medicine. Foetal lamb
cells (freeze dried or fresh frozen) or filtered liquid extracts of these cells seem to induce tissue
specific structural and functional regeneration in disorders related to the connective tissue,
neurological, vascular, respiratory, digestive and immune systems. Organ extract- and cell
therapy in either form is not new, and is allowed by the US Food and Drug Administration
(FDA) for use by licensed physicians in investigational protocols under natural products
guidelines. Delay in generalised acceptance and application of organ extract and cell therapy in
the United States and Asia has been related to the failure of university teaching centres to instruct
in this modality, to pharmaceutical industry influence, and to the fact that nearly all the literature
was previously in German. A wealth of peer reviewed basic science and clinical publications
around the world now document the mechanism of action and efficacy of organ extract- and cell
therapy in a number of forms, regardless of terminology.
The two pathways to health are not mutually exclusive, nor should they be considered
necessarily competitive. Allopathic regimes tend to work better against emergency or acute
problems such as trauma, rapid tissue failure, acute inflammation and infection. Organ extract-
and cell therapy is more oriented to chronic degenerative diseases, non-healing wounds, immune
incompetence, virus related tumour therapy, disturbed childhood development, premature
ageing, chronic allergies, and endocrine (glandular) dysfunction. Neither therapeutic philosophy
can assure a trouble free life, claim miraculous cures, guarantee success, or insure against any
adverse reaction or complication. Even when applied with wisdom, competence, and the best of
intent, all human therapies can fail, complicate, or hasten death.
ORGAN EXTRACT- AND CELL THERAPY IN ANTI-AGEING
Ageing is one of the most natural processes and, strictly speaking, defines earthly life's time
limit. All earthly life is subject to wear and deterioration, a process which, in fact, begins shortly
after birth. Mankind has always dreamed of halting the degenerative ageing process and turning
back the clock to attain eternal youth. Nature, of course, always denied us fulfilment of this age
old wish. Recently, epoch making advances in medical science have assured us that the average
life expectancy will become significantly longer. As a result, the human organism will be
subjected to a significantly longer period of wear. Although the degenerative ageing process is
inevitable, it can be reduced or dramatically slowed with specific organ extract- and cell therapy
in the context of detoxification, bio-terrain correction, and other biological therapy. American
allopathic drug based medicine today is at the avant-garde in crisis transplantation of hearts,
kidneys and livers. However, the allopathic physician usually treats symptoms of ageing and
disease with artificially synthesised, frequently toxic chemicals which are not found in the
English Language Arts and Mathematics Tests Preliminary Results Spring 2015 Administration Highlights The new Ohio State Tests in English language arts and mathematics were administered for the first time during the 2014-2015 school year. These tests were produced by the Partnership for Assessment of Readiness …
Employment Application Cummins Location: Today's Date: Reviewed By: Date available to start work: Print name in full: LAST FIRST MIDDLE Social Security No.: Salary expected: Present address: City: State & Zip Code: Previous addresses over the past 10 years: Email address: Phone No. & Area …
Live your life, enjoy your life A guide to using your health plan In a hurry? Pages 45 shows where to find your medical plan information online quickly at myuhc.com. Welcome We're glad you're here. While no one can predict t the future, , you …
Fetal Pig Dissection Labs Dr. J. Lim Objective: In this exercise you will examine the organization of the many body systems studied this semester in the context of a single specimen, the fetal pig. Be sure to identify the major organs as you explore the …